CHESSA, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 34.376
NA - Nord America 2.485
AS - Asia 1.386
SA - Sud America 192
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 31
OC - Oceania 4
Totale 38.665
Nazione #
IT - Italia 33.831
US - Stati Uniti d'America 2.416
SG - Singapore 550
CN - Cina 356
VN - Vietnam 146
BR - Brasile 141
SE - Svezia 109
DE - Germania 99
FI - Finlandia 94
FR - Francia 59
GB - Regno Unito 53
HK - Hong Kong 50
CA - Canada 43
IN - India 43
JP - Giappone 34
TR - Turchia 32
BD - Bangladesh 31
IQ - Iraq 29
ES - Italia 25
KR - Corea 21
NL - Olanda 20
UA - Ucraina 19
IR - Iran 12
PK - Pakistan 12
AR - Argentina 11
AT - Austria 11
EC - Ecuador 11
MX - Messico 11
CL - Cile 10
ID - Indonesia 10
PL - Polonia 10
UZ - Uzbekistan 9
ZA - Sudafrica 8
EG - Egitto 7
GR - Grecia 7
IE - Irlanda 7
CO - Colombia 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
PH - Filippine 6
RU - Federazione Russa 6
AZ - Azerbaigian 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
JO - Giordania 4
PE - Perù 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
TW - Taiwan 4
VE - Venezuela 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
PA - Panama 3
RO - Romania 3
TN - Tunisia 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
BG - Bulgaria 1
BZ - Belize 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 38.474
Città #
Cagliari 32.229
Uta 1.344
Dallas 332
Singapore 328
Ashburn 295
San Jose 175
Boardman 114
Fairfield 105
Council Bluffs 94
Helsinki 80
Chandler 68
Beijing 66
Los Angeles 60
New York 58
Woodbridge 57
Nyköping 53
Santa Clara 50
Shanghai 49
The Dalles 46
Houston 44
Hong Kong 43
Seattle 41
Ho Chi Minh City 37
Cambridge 35
Hefei 35
Wilmington 34
Rome 31
Hanoi 30
Lauterbourg 29
Munich 29
Ann Arbor 28
Chicago 26
Istanbul 26
Milan 24
Boston 23
Buffalo 23
Columbus 23
Dong Ket 22
Seoul 20
Baghdad 18
Redwood City 18
Nuremberg 16
Tokyo 16
Orem 15
Dearborn 14
Jacksonville 14
London 14
Toronto 13
Madrid 12
Redondo Beach 12
São Paulo 12
Denver 11
Frankfurt am Main 11
Montreal 11
Phoenix 11
Atlanta 10
Brooklyn 10
Paris 10
Tashkent 9
Amsterdam 8
Elk Grove Village 8
Salt Lake City 8
Selargius 8
Vienna 8
Düsseldorf 7
Haiphong 7
Lappeenranta 7
Mumbai 7
Nanjing 7
San Diego 7
Santiago 7
Belo Horizonte 6
Da Nang 6
Erbil 6
Hyderabad 6
North Bergen 6
Salvador 6
Shenzhen 6
Tampa 6
Turku 6
Warsaw 6
Chennai 5
Dhaka 5
Mountain View 5
Naples 5
Sestu 5
Baku 4
Brno 4
Charlotte 4
Dongguan 4
Guayaquil 4
Johannesburg 4
Lahore 4
Manchester 4
Mexico City 4
Miami 4
Ponte di Piave 4
Poplar 4
Princeton 4
Pune 4
Totale 36.693
Nome #
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.188
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.075
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.625
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.347
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.291
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.186
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.664
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.586
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.367
null 1.241
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.207
Targeted Therapies in Axial Psoriatic Arthritis 1.188
Physician global assessment in systemic lupus erythematosus: Can we rely on its reliability? 1.146
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.093
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.078
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.071
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.060
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 1.010
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 940
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 921
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 902
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 785
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study 742
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 637
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 568
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 521
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus 508
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 354
Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events 264
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease 261
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 249
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 188
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 123
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 80
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 75
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 65
Machine Learning for MRI Classification of Systemic Lupus Erythematous Patients with and without Neuropsychiatric Events 33
Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature review 26
Totale 38.665
Categoria #
all - tutte 53.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.093 0 95 121 76 150 107 137 139 192 263 450 363
2022/20233.547 363 503 387 268 260 442 198 251 232 238 259 146
2023/20246.327 108 178 215 456 550 673 590 2.199 243 224 457 434
2024/202513.031 4.007 4.241 1.249 1.139 566 606 652 56 114 116 166 119
2025/20263.396 212 222 365 222 257 225 635 253 305 334 269 97
2026/2027379 168 211 0 0 0 0 0 0 0 0 0 0
Totale 38.665